date,title,source
Oct-17-18,Todays Research Reports on Stocks to Watch: Altimmune and MannKind,ACCESSWIRE
Oct-24-18,"Research Report Identifies Cato, Roadrunner Transportation, Talend S.A, Vi, MannKind, and Acceleron Pharma with Renewed Outlook  Fundamental Analysis, Calculating Forward Movement",GlobeNewswire
Oct-25-18,"MannKind Corporation to Hold 2018 Third Quarter Financial Results Conference Call on November 1, 2018",GlobeNewswire
Oct-31-18,United Therapeutics Corp (UTHR) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Nov-01-18,Edited Transcript of MNKD earnings conference call or presentation 1-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-01-18,MannKind: 3Q Earnings Snapshot,Associated Press
Nov-01-18,MannKind Corporation Reports 2018 Third Quarter Financial Results,GlobeNewswire
Nov-15-18,Edited Transcript of MNKD earnings conference call or presentation 1-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-16-18,Edited Transcript of MNKD earnings conference call or presentation 1-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-27-18,MannKind Appoints Christine Mundkur to its Board of Directors,GlobeNewswire
Nov-27-18,Analysts: Why United Therapeutics has had a streak of licensing deals,American City Business Journals
Dec-10-18,Biotech Stocks Beating the Market,ACCESSWIRE
Dec-11-18,MNKD: Zacks SCR Initiates Coverage of MannKind With $4.25/share Price Target,Zacks Small Cap Research
Dec-19-18,MannKind Announces Commencement of Public Offering,GlobeNewswire
